Knocking down IQGAP1 using shRNA reduced the abilities of pancreatic cancer cells to proliferate and migrate and reduced the incidence of tumor formation and liver metastases in pancreatic cancer xenograft models in vivo [125,126]. Here, IQGAP1 is linked to familial pancreatic carcinoma.